Global Genetic Screening for Carrier Diseases Market 2026 by Company, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Genetic Screening for Carrier Diseases market size was valued at US$ 2690 million in 2025 and is forecast to a readjusted size of US$ 4895 million by 2032 with a CAGR of 9.0% during review period.
Genetic Screening for Carrier Diseases refers to detecting whether an individual carries the causative gene of a certain genetic disease. In human genetics, some diseases are caused by recessively inherited gene mutations. These mutations usually do not cause the disease in the individual themselves, but if two carriers have offspring, they may increase the risk of the offspring suffering from the genetic disease. Genetic screening for genetic disease carriers can help individuals, especially couples planning to have children, by helping to assess the risk of their future offspring developing specific genetic diseases. If both partners are carriers, they are more likely to have offspring with the disease. Through this screening, couples can better understand their genetic status, make more informed reproductive decisions, and seek genetic counseling and medical intervention when needed.
The genetic screening for carrier diseases market is transitioning from a niche, risk-based offering into a more standardized element of reproductive care as clinical practice moves toward earlier identification of inherited risk and simpler pan-ethnic approaches. Growth is supported by declining sequencing costs, expanding awareness among patients and clinicians, and the operational convenience of comprehensive panels that reduce reliance on ancestry assumptions. Competitive differentiation increasingly depends on the quality and consistency of variant interpretation, the clarity of reporting for non-specialist providers, turnaround time, and the ability to embed testing into fertility, obstetrics, and primary care workflows with counseling support and digital ordering. At the same time, the market faces reimbursement and pricing pressure, which favors scaled laboratory operations, efficient logistics, and evidence generation that links screening to measurable clinical utility and downstream cost avoidance.
This report is a detailed and comprehensive analysis for global Genetic Screening for Carrier Diseases market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Genetic Screening for Carrier Diseases market size and forecasts, in consumption value ($ Million), 2021-2032
Global Genetic Screening for Carrier Diseases market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Genetic Screening for Carrier Diseases market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Genetic Screening for Carrier Diseases market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Genetic Screening for Carrier Diseases
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Genetic Screening for Carrier Diseases market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Eurofins Scientific, Illumina, Labcorp, Quest Diagnostics, MedGenome, Myriad Genetics, Natera, OPKO Health, 23andMe, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Genetic Screening for Carrier Diseases market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Genetic Screening for Carrier Diseases product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Genetic Screening for Carrier Diseases, with revenue, gross margin, and global market share of Genetic Screening for Carrier Diseases from 2021 to 2026.
Chapter 3, the Genetic Screening for Carrier Diseases competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Genetic Screening for Carrier Diseases market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Genetic Screening for Carrier Diseases.
Chapter 13, to describe Genetic Screening for Carrier Diseases research findings and conclusion.
Genetic Screening for Carrier Diseases refers to detecting whether an individual carries the causative gene of a certain genetic disease. In human genetics, some diseases are caused by recessively inherited gene mutations. These mutations usually do not cause the disease in the individual themselves, but if two carriers have offspring, they may increase the risk of the offspring suffering from the genetic disease. Genetic screening for genetic disease carriers can help individuals, especially couples planning to have children, by helping to assess the risk of their future offspring developing specific genetic diseases. If both partners are carriers, they are more likely to have offspring with the disease. Through this screening, couples can better understand their genetic status, make more informed reproductive decisions, and seek genetic counseling and medical intervention when needed.
The genetic screening for carrier diseases market is transitioning from a niche, risk-based offering into a more standardized element of reproductive care as clinical practice moves toward earlier identification of inherited risk and simpler pan-ethnic approaches. Growth is supported by declining sequencing costs, expanding awareness among patients and clinicians, and the operational convenience of comprehensive panels that reduce reliance on ancestry assumptions. Competitive differentiation increasingly depends on the quality and consistency of variant interpretation, the clarity of reporting for non-specialist providers, turnaround time, and the ability to embed testing into fertility, obstetrics, and primary care workflows with counseling support and digital ordering. At the same time, the market faces reimbursement and pricing pressure, which favors scaled laboratory operations, efficient logistics, and evidence generation that links screening to measurable clinical utility and downstream cost avoidance.
This report is a detailed and comprehensive analysis for global Genetic Screening for Carrier Diseases market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Genetic Screening for Carrier Diseases market size and forecasts, in consumption value ($ Million), 2021-2032
Global Genetic Screening for Carrier Diseases market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Genetic Screening for Carrier Diseases market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Genetic Screening for Carrier Diseases market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Genetic Screening for Carrier Diseases
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Genetic Screening for Carrier Diseases market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Eurofins Scientific, Illumina, Labcorp, Quest Diagnostics, MedGenome, Myriad Genetics, Natera, OPKO Health, 23andMe, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Genetic Screening for Carrier Diseases market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- NGS
- Whole Exome Sequencing
- Others
- Preconception Screening
- Prenatal Screening
- Single-condition Screening
- Targeted multi-condition Screening
- Couple
- Individual
- Thermo Fisher Scientific
- Eurofins Scientific
- Illumina
- Labcorp
- Quest Diagnostics
- MedGenome
- Myriad Genetics
- Natera
- OPKO Health
- 23andMe
- Mayo Clinic Laboratories
- Baylor Genetics
- GeneDx
- Fulgent Genetics
- NxGen MDx
- Sonic Genetics
- Ambry Genetics
- PreventionGenetics
- DiaSorin
- SYNLAB
- BGI Genomics
- Berry Genomics
- Annaroad
- Jiajian Medical Testing
- Genesky
- Weihansi Biomedical Technology
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Genetic Screening for Carrier Diseases product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Genetic Screening for Carrier Diseases, with revenue, gross margin, and global market share of Genetic Screening for Carrier Diseases from 2021 to 2026.
Chapter 3, the Genetic Screening for Carrier Diseases competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Genetic Screening for Carrier Diseases market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Genetic Screening for Carrier Diseases.
Chapter 13, to describe Genetic Screening for Carrier Diseases research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Genetic Screening for Carrier Diseases by Type
1.3.1 Overview: Global Genetic Screening for Carrier Diseases Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Genetic Screening for Carrier Diseases Consumption Value Market Share by Type in 2025
1.3.3 NGS
1.3.4 Whole Exome Sequencing
1.3.5 Others
1.4 Classification of Genetic Screening for Carrier Diseases by Screening Timing
1.4.1 Overview: Global Genetic Screening for Carrier Diseases Market Size by Screening Timing: 2021 Versus 2025 Versus 2032
1.4.2 Global Genetic Screening for Carrier Diseases Consumption Value Market Share by Screening Timing in 2025
1.4.3 Preconception Screening
1.4.4 Prenatal Screening
1.5 Classification of Genetic Screening for Carrier Diseases by Screening Scope
1.5.1 Overview: Global Genetic Screening for Carrier Diseases Market Size by Screening Scope: 2021 Versus 2025 Versus 2032
1.5.2 Global Genetic Screening for Carrier Diseases Consumption Value Market Share by Screening Scope in 2025
1.5.3 Single-condition Screening
1.5.4 Targeted multi-condition Screening
1.6 Global Genetic Screening for Carrier Diseases Market by Application
1.6.1 Overview: Global Genetic Screening for Carrier Diseases Market Size by Application: 2021 Versus 2025 Versus 2032
1.6.2 Couple
1.6.3 Individual
1.7 Global Genetic Screening for Carrier Diseases Market Size & Forecast
1.8 Global Genetic Screening for Carrier Diseases Market Size and Forecast by Region
1.8.1 Global Genetic Screening for Carrier Diseases Market Size by Region: 2021 VS 2025 VS 2032
1.8.2 Global Genetic Screening for Carrier Diseases Market Size by Region, (2021-2032)
1.8.3 North America Genetic Screening for Carrier Diseases Market Size and Prospect (2021-2032)
1.8.4 Europe Genetic Screening for Carrier Diseases Market Size and Prospect (2021-2032)
1.8.5 Asia-Pacific Genetic Screening for Carrier Diseases Market Size and Prospect (2021-2032)
1.8.6 South America Genetic Screening for Carrier Diseases Market Size and Prospect (2021-2032)
1.8.7 Middle East & Africa Genetic Screening for Carrier Diseases Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Thermo Fisher Scientific
2.1.1 Thermo Fisher Scientific Details
2.1.2 Thermo Fisher Scientific Major Business
2.1.3 Thermo Fisher Scientific Genetic Screening for Carrier Diseases Product and Solutions
2.1.4 Thermo Fisher Scientific Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.2 Eurofins Scientific
2.2.1 Eurofins Scientific Details
2.2.2 Eurofins Scientific Major Business
2.2.3 Eurofins Scientific Genetic Screening for Carrier Diseases Product and Solutions
2.2.4 Eurofins Scientific Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Eurofins Scientific Recent Developments and Future Plans
2.3 Illumina
2.3.1 Illumina Details
2.3.2 Illumina Major Business
2.3.3 Illumina Genetic Screening for Carrier Diseases Product and Solutions
2.3.4 Illumina Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Illumina Recent Developments and Future Plans
2.4 Labcorp
2.4.1 Labcorp Details
2.4.2 Labcorp Major Business
2.4.3 Labcorp Genetic Screening for Carrier Diseases Product and Solutions
2.4.4 Labcorp Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Labcorp Recent Developments and Future Plans
2.5 Quest Diagnostics
2.5.1 Quest Diagnostics Details
2.5.2 Quest Diagnostics Major Business
2.5.3 Quest Diagnostics Genetic Screening for Carrier Diseases Product and Solutions
2.5.4 Quest Diagnostics Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Quest Diagnostics Recent Developments and Future Plans
2.6 MedGenome
2.6.1 MedGenome Details
2.6.2 MedGenome Major Business
2.6.3 MedGenome Genetic Screening for Carrier Diseases Product and Solutions
2.6.4 MedGenome Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 MedGenome Recent Developments and Future Plans
2.7 Myriad Genetics
2.7.1 Myriad Genetics Details
2.7.2 Myriad Genetics Major Business
2.7.3 Myriad Genetics Genetic Screening for Carrier Diseases Product and Solutions
2.7.4 Myriad Genetics Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Myriad Genetics Recent Developments and Future Plans
2.8 Natera
2.8.1 Natera Details
2.8.2 Natera Major Business
2.8.3 Natera Genetic Screening for Carrier Diseases Product and Solutions
2.8.4 Natera Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Natera Recent Developments and Future Plans
2.9 OPKO Health
2.9.1 OPKO Health Details
2.9.2 OPKO Health Major Business
2.9.3 OPKO Health Genetic Screening for Carrier Diseases Product and Solutions
2.9.4 OPKO Health Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 OPKO Health Recent Developments and Future Plans
2.10 23andMe
2.10.1 23andMe Details
2.10.2 23andMe Major Business
2.10.3 23andMe Genetic Screening for Carrier Diseases Product and Solutions
2.10.4 23andMe Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 23andMe Recent Developments and Future Plans
2.11 Mayo Clinic Laboratories
2.11.1 Mayo Clinic Laboratories Details
2.11.2 Mayo Clinic Laboratories Major Business
2.11.3 Mayo Clinic Laboratories Genetic Screening for Carrier Diseases Product and Solutions
2.11.4 Mayo Clinic Laboratories Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Mayo Clinic Laboratories Recent Developments and Future Plans
2.12 Baylor Genetics
2.12.1 Baylor Genetics Details
2.12.2 Baylor Genetics Major Business
2.12.3 Baylor Genetics Genetic Screening for Carrier Diseases Product and Solutions
2.12.4 Baylor Genetics Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Baylor Genetics Recent Developments and Future Plans
2.13 GeneDx
2.13.1 GeneDx Details
2.13.2 GeneDx Major Business
2.13.3 GeneDx Genetic Screening for Carrier Diseases Product and Solutions
2.13.4 GeneDx Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 GeneDx Recent Developments and Future Plans
2.14 Fulgent Genetics
2.14.1 Fulgent Genetics Details
2.14.2 Fulgent Genetics Major Business
2.14.3 Fulgent Genetics Genetic Screening for Carrier Diseases Product and Solutions
2.14.4 Fulgent Genetics Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Fulgent Genetics Recent Developments and Future Plans
2.15 NxGen MDx
2.15.1 NxGen MDx Details
2.15.2 NxGen MDx Major Business
2.15.3 NxGen MDx Genetic Screening for Carrier Diseases Product and Solutions
2.15.4 NxGen MDx Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 NxGen MDx Recent Developments and Future Plans
2.16 Sonic Genetics
2.16.1 Sonic Genetics Details
2.16.2 Sonic Genetics Major Business
2.16.3 Sonic Genetics Genetic Screening for Carrier Diseases Product and Solutions
2.16.4 Sonic Genetics Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Sonic Genetics Recent Developments and Future Plans
2.17 Ambry Genetics
2.17.1 Ambry Genetics Details
2.17.2 Ambry Genetics Major Business
2.17.3 Ambry Genetics Genetic Screening for Carrier Diseases Product and Solutions
2.17.4 Ambry Genetics Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Ambry Genetics Recent Developments and Future Plans
2.18 PreventionGenetics
2.18.1 PreventionGenetics Details
2.18.2 PreventionGenetics Major Business
2.18.3 PreventionGenetics Genetic Screening for Carrier Diseases Product and Solutions
2.18.4 PreventionGenetics Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 PreventionGenetics Recent Developments and Future Plans
2.19 DiaSorin
2.19.1 DiaSorin Details
2.19.2 DiaSorin Major Business
2.19.3 DiaSorin Genetic Screening for Carrier Diseases Product and Solutions
2.19.4 DiaSorin Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
2.19.5 DiaSorin Recent Developments and Future Plans
2.20 SYNLAB
2.20.1 SYNLAB Details
2.20.2 SYNLAB Major Business
2.20.3 SYNLAB Genetic Screening for Carrier Diseases Product and Solutions
2.20.4 SYNLAB Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
2.20.5 SYNLAB Recent Developments and Future Plans
2.21 BGI Genomics
2.21.1 BGI Genomics Details
2.21.2 BGI Genomics Major Business
2.21.3 BGI Genomics Genetic Screening for Carrier Diseases Product and Solutions
2.21.4 BGI Genomics Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
2.21.5 BGI Genomics Recent Developments and Future Plans
2.22 Berry Genomics
2.22.1 Berry Genomics Details
2.22.2 Berry Genomics Major Business
2.22.3 Berry Genomics Genetic Screening for Carrier Diseases Product and Solutions
2.22.4 Berry Genomics Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
2.22.5 Berry Genomics Recent Developments and Future Plans
2.23 Annaroad
2.23.1 Annaroad Details
2.23.2 Annaroad Major Business
2.23.3 Annaroad Genetic Screening for Carrier Diseases Product and Solutions
2.23.4 Annaroad Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
2.23.5 Annaroad Recent Developments and Future Plans
2.24 Jiajian Medical Testing
2.24.1 Jiajian Medical Testing Details
2.24.2 Jiajian Medical Testing Major Business
2.24.3 Jiajian Medical Testing Genetic Screening for Carrier Diseases Product and Solutions
2.24.4 Jiajian Medical Testing Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
2.24.5 Jiajian Medical Testing Recent Developments and Future Plans
2.25 Genesky
2.25.1 Genesky Details
2.25.2 Genesky Major Business
2.25.3 Genesky Genetic Screening for Carrier Diseases Product and Solutions
2.25.4 Genesky Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
2.25.5 Genesky Recent Developments and Future Plans
2.26 Weihansi Biomedical Technology
2.26.1 Weihansi Biomedical Technology Details
2.26.2 Weihansi Biomedical Technology Major Business
2.26.3 Weihansi Biomedical Technology Genetic Screening for Carrier Diseases Product and Solutions
2.26.4 Weihansi Biomedical Technology Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
2.26.5 Weihansi Biomedical Technology Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Genetic Screening for Carrier Diseases Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Genetic Screening for Carrier Diseases by Company Revenue
3.2.2 Top 3 Genetic Screening for Carrier Diseases Players Market Share in 2025
3.2.3 Top 6 Genetic Screening for Carrier Diseases Players Market Share in 2025
3.3 Genetic Screening for Carrier Diseases Market: Overall Company Footprint Analysis
3.3.1 Genetic Screening for Carrier Diseases Market: Region Footprint
3.3.2 Genetic Screening for Carrier Diseases Market: Company Product Type Footprint
3.3.3 Genetic Screening for Carrier Diseases Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Genetic Screening for Carrier Diseases Consumption Value and Market Share by Type (2021-2026)
4.2 Global Genetic Screening for Carrier Diseases Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Genetic Screening for Carrier Diseases Consumption Value Market Share by Application (2021-2026)
5.2 Global Genetic Screening for Carrier Diseases Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Genetic Screening for Carrier Diseases Consumption Value by Type (2021-2032)
6.2 North America Genetic Screening for Carrier Diseases Market Size by Application (2021-2032)
6.3 North America Genetic Screening for Carrier Diseases Market Size by Country
6.3.1 North America Genetic Screening for Carrier Diseases Consumption Value by Country (2021-2032)
6.3.2 United States Genetic Screening for Carrier Diseases Market Size and Forecast (2021-2032)
6.3.3 Canada Genetic Screening for Carrier Diseases Market Size and Forecast (2021-2032)
6.3.4 Mexico Genetic Screening for Carrier Diseases Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Genetic Screening for Carrier Diseases Consumption Value by Type (2021-2032)
7.2 Europe Genetic Screening for Carrier Diseases Consumption Value by Application (2021-2032)
7.3 Europe Genetic Screening for Carrier Diseases Market Size by Country
7.3.1 Europe Genetic Screening for Carrier Diseases Consumption Value by Country (2021-2032)
7.3.2 Germany Genetic Screening for Carrier Diseases Market Size and Forecast (2021-2032)
7.3.3 France Genetic Screening for Carrier Diseases Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Genetic Screening for Carrier Diseases Market Size and Forecast (2021-2032)
7.3.5 Russia Genetic Screening for Carrier Diseases Market Size and Forecast (2021-2032)
7.3.6 Italy Genetic Screening for Carrier Diseases Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Genetic Screening for Carrier Diseases Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Genetic Screening for Carrier Diseases Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Genetic Screening for Carrier Diseases Market Size by Region
8.3.1 Asia-Pacific Genetic Screening for Carrier Diseases Consumption Value by Region (2021-2032)
8.3.2 China Genetic Screening for Carrier Diseases Market Size and Forecast (2021-2032)
8.3.3 Japan Genetic Screening for Carrier Diseases Market Size and Forecast (2021-2032)
8.3.4 South Korea Genetic Screening for Carrier Diseases Market Size and Forecast (2021-2032)
8.3.5 India Genetic Screening for Carrier Diseases Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Genetic Screening for Carrier Diseases Market Size and Forecast (2021-2032)
8.3.7 Australia Genetic Screening for Carrier Diseases Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Genetic Screening for Carrier Diseases Consumption Value by Type (2021-2032)
9.2 South America Genetic Screening for Carrier Diseases Consumption Value by Application (2021-2032)
9.3 South America Genetic Screening for Carrier Diseases Market Size by Country
9.3.1 South America Genetic Screening for Carrier Diseases Consumption Value by Country (2021-2032)
9.3.2 Brazil Genetic Screening for Carrier Diseases Market Size and Forecast (2021-2032)
9.3.3 Argentina Genetic Screening for Carrier Diseases Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Genetic Screening for Carrier Diseases Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Genetic Screening for Carrier Diseases Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Genetic Screening for Carrier Diseases Market Size by Country
10.3.1 Middle East & Africa Genetic Screening for Carrier Diseases Consumption Value by Country (2021-2032)
10.3.2 Turkey Genetic Screening for Carrier Diseases Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Genetic Screening for Carrier Diseases Market Size and Forecast (2021-2032)
10.3.4 UAE Genetic Screening for Carrier Diseases Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Genetic Screening for Carrier Diseases Market Drivers
11.2 Genetic Screening for Carrier Diseases Market Restraints
11.3 Genetic Screening for Carrier Diseases Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Genetic Screening for Carrier Diseases Industry Chain
12.2 Genetic Screening for Carrier Diseases Upstream Analysis
12.3 Genetic Screening for Carrier Diseases Midstream Analysis
12.4 Genetic Screening for Carrier Diseases Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Genetic Screening for Carrier Diseases by Type
1.3.1 Overview: Global Genetic Screening for Carrier Diseases Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Genetic Screening for Carrier Diseases Consumption Value Market Share by Type in 2025
1.3.3 NGS
1.3.4 Whole Exome Sequencing
1.3.5 Others
1.4 Classification of Genetic Screening for Carrier Diseases by Screening Timing
1.4.1 Overview: Global Genetic Screening for Carrier Diseases Market Size by Screening Timing: 2021 Versus 2025 Versus 2032
1.4.2 Global Genetic Screening for Carrier Diseases Consumption Value Market Share by Screening Timing in 2025
1.4.3 Preconception Screening
1.4.4 Prenatal Screening
1.5 Classification of Genetic Screening for Carrier Diseases by Screening Scope
1.5.1 Overview: Global Genetic Screening for Carrier Diseases Market Size by Screening Scope: 2021 Versus 2025 Versus 2032
1.5.2 Global Genetic Screening for Carrier Diseases Consumption Value Market Share by Screening Scope in 2025
1.5.3 Single-condition Screening
1.5.4 Targeted multi-condition Screening
1.6 Global Genetic Screening for Carrier Diseases Market by Application
1.6.1 Overview: Global Genetic Screening for Carrier Diseases Market Size by Application: 2021 Versus 2025 Versus 2032
1.6.2 Couple
1.6.3 Individual
1.7 Global Genetic Screening for Carrier Diseases Market Size & Forecast
1.8 Global Genetic Screening for Carrier Diseases Market Size and Forecast by Region
1.8.1 Global Genetic Screening for Carrier Diseases Market Size by Region: 2021 VS 2025 VS 2032
1.8.2 Global Genetic Screening for Carrier Diseases Market Size by Region, (2021-2032)
1.8.3 North America Genetic Screening for Carrier Diseases Market Size and Prospect (2021-2032)
1.8.4 Europe Genetic Screening for Carrier Diseases Market Size and Prospect (2021-2032)
1.8.5 Asia-Pacific Genetic Screening for Carrier Diseases Market Size and Prospect (2021-2032)
1.8.6 South America Genetic Screening for Carrier Diseases Market Size and Prospect (2021-2032)
1.8.7 Middle East & Africa Genetic Screening for Carrier Diseases Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Thermo Fisher Scientific
2.1.1 Thermo Fisher Scientific Details
2.1.2 Thermo Fisher Scientific Major Business
2.1.3 Thermo Fisher Scientific Genetic Screening for Carrier Diseases Product and Solutions
2.1.4 Thermo Fisher Scientific Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.2 Eurofins Scientific
2.2.1 Eurofins Scientific Details
2.2.2 Eurofins Scientific Major Business
2.2.3 Eurofins Scientific Genetic Screening for Carrier Diseases Product and Solutions
2.2.4 Eurofins Scientific Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Eurofins Scientific Recent Developments and Future Plans
2.3 Illumina
2.3.1 Illumina Details
2.3.2 Illumina Major Business
2.3.3 Illumina Genetic Screening for Carrier Diseases Product and Solutions
2.3.4 Illumina Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Illumina Recent Developments and Future Plans
2.4 Labcorp
2.4.1 Labcorp Details
2.4.2 Labcorp Major Business
2.4.3 Labcorp Genetic Screening for Carrier Diseases Product and Solutions
2.4.4 Labcorp Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Labcorp Recent Developments and Future Plans
2.5 Quest Diagnostics
2.5.1 Quest Diagnostics Details
2.5.2 Quest Diagnostics Major Business
2.5.3 Quest Diagnostics Genetic Screening for Carrier Diseases Product and Solutions
2.5.4 Quest Diagnostics Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Quest Diagnostics Recent Developments and Future Plans
2.6 MedGenome
2.6.1 MedGenome Details
2.6.2 MedGenome Major Business
2.6.3 MedGenome Genetic Screening for Carrier Diseases Product and Solutions
2.6.4 MedGenome Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 MedGenome Recent Developments and Future Plans
2.7 Myriad Genetics
2.7.1 Myriad Genetics Details
2.7.2 Myriad Genetics Major Business
2.7.3 Myriad Genetics Genetic Screening for Carrier Diseases Product and Solutions
2.7.4 Myriad Genetics Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Myriad Genetics Recent Developments and Future Plans
2.8 Natera
2.8.1 Natera Details
2.8.2 Natera Major Business
2.8.3 Natera Genetic Screening for Carrier Diseases Product and Solutions
2.8.4 Natera Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Natera Recent Developments and Future Plans
2.9 OPKO Health
2.9.1 OPKO Health Details
2.9.2 OPKO Health Major Business
2.9.3 OPKO Health Genetic Screening for Carrier Diseases Product and Solutions
2.9.4 OPKO Health Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 OPKO Health Recent Developments and Future Plans
2.10 23andMe
2.10.1 23andMe Details
2.10.2 23andMe Major Business
2.10.3 23andMe Genetic Screening for Carrier Diseases Product and Solutions
2.10.4 23andMe Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 23andMe Recent Developments and Future Plans
2.11 Mayo Clinic Laboratories
2.11.1 Mayo Clinic Laboratories Details
2.11.2 Mayo Clinic Laboratories Major Business
2.11.3 Mayo Clinic Laboratories Genetic Screening for Carrier Diseases Product and Solutions
2.11.4 Mayo Clinic Laboratories Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Mayo Clinic Laboratories Recent Developments and Future Plans
2.12 Baylor Genetics
2.12.1 Baylor Genetics Details
2.12.2 Baylor Genetics Major Business
2.12.3 Baylor Genetics Genetic Screening for Carrier Diseases Product and Solutions
2.12.4 Baylor Genetics Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Baylor Genetics Recent Developments and Future Plans
2.13 GeneDx
2.13.1 GeneDx Details
2.13.2 GeneDx Major Business
2.13.3 GeneDx Genetic Screening for Carrier Diseases Product and Solutions
2.13.4 GeneDx Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 GeneDx Recent Developments and Future Plans
2.14 Fulgent Genetics
2.14.1 Fulgent Genetics Details
2.14.2 Fulgent Genetics Major Business
2.14.3 Fulgent Genetics Genetic Screening for Carrier Diseases Product and Solutions
2.14.4 Fulgent Genetics Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Fulgent Genetics Recent Developments and Future Plans
2.15 NxGen MDx
2.15.1 NxGen MDx Details
2.15.2 NxGen MDx Major Business
2.15.3 NxGen MDx Genetic Screening for Carrier Diseases Product and Solutions
2.15.4 NxGen MDx Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 NxGen MDx Recent Developments and Future Plans
2.16 Sonic Genetics
2.16.1 Sonic Genetics Details
2.16.2 Sonic Genetics Major Business
2.16.3 Sonic Genetics Genetic Screening for Carrier Diseases Product and Solutions
2.16.4 Sonic Genetics Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Sonic Genetics Recent Developments and Future Plans
2.17 Ambry Genetics
2.17.1 Ambry Genetics Details
2.17.2 Ambry Genetics Major Business
2.17.3 Ambry Genetics Genetic Screening for Carrier Diseases Product and Solutions
2.17.4 Ambry Genetics Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Ambry Genetics Recent Developments and Future Plans
2.18 PreventionGenetics
2.18.1 PreventionGenetics Details
2.18.2 PreventionGenetics Major Business
2.18.3 PreventionGenetics Genetic Screening for Carrier Diseases Product and Solutions
2.18.4 PreventionGenetics Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 PreventionGenetics Recent Developments and Future Plans
2.19 DiaSorin
2.19.1 DiaSorin Details
2.19.2 DiaSorin Major Business
2.19.3 DiaSorin Genetic Screening for Carrier Diseases Product and Solutions
2.19.4 DiaSorin Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
2.19.5 DiaSorin Recent Developments and Future Plans
2.20 SYNLAB
2.20.1 SYNLAB Details
2.20.2 SYNLAB Major Business
2.20.3 SYNLAB Genetic Screening for Carrier Diseases Product and Solutions
2.20.4 SYNLAB Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
2.20.5 SYNLAB Recent Developments and Future Plans
2.21 BGI Genomics
2.21.1 BGI Genomics Details
2.21.2 BGI Genomics Major Business
2.21.3 BGI Genomics Genetic Screening for Carrier Diseases Product and Solutions
2.21.4 BGI Genomics Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
2.21.5 BGI Genomics Recent Developments and Future Plans
2.22 Berry Genomics
2.22.1 Berry Genomics Details
2.22.2 Berry Genomics Major Business
2.22.3 Berry Genomics Genetic Screening for Carrier Diseases Product and Solutions
2.22.4 Berry Genomics Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
2.22.5 Berry Genomics Recent Developments and Future Plans
2.23 Annaroad
2.23.1 Annaroad Details
2.23.2 Annaroad Major Business
2.23.3 Annaroad Genetic Screening for Carrier Diseases Product and Solutions
2.23.4 Annaroad Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
2.23.5 Annaroad Recent Developments and Future Plans
2.24 Jiajian Medical Testing
2.24.1 Jiajian Medical Testing Details
2.24.2 Jiajian Medical Testing Major Business
2.24.3 Jiajian Medical Testing Genetic Screening for Carrier Diseases Product and Solutions
2.24.4 Jiajian Medical Testing Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
2.24.5 Jiajian Medical Testing Recent Developments and Future Plans
2.25 Genesky
2.25.1 Genesky Details
2.25.2 Genesky Major Business
2.25.3 Genesky Genetic Screening for Carrier Diseases Product and Solutions
2.25.4 Genesky Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
2.25.5 Genesky Recent Developments and Future Plans
2.26 Weihansi Biomedical Technology
2.26.1 Weihansi Biomedical Technology Details
2.26.2 Weihansi Biomedical Technology Major Business
2.26.3 Weihansi Biomedical Technology Genetic Screening for Carrier Diseases Product and Solutions
2.26.4 Weihansi Biomedical Technology Genetic Screening for Carrier Diseases Revenue, Gross Margin and Market Share (2021-2026)
2.26.5 Weihansi Biomedical Technology Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Genetic Screening for Carrier Diseases Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Genetic Screening for Carrier Diseases by Company Revenue
3.2.2 Top 3 Genetic Screening for Carrier Diseases Players Market Share in 2025
3.2.3 Top 6 Genetic Screening for Carrier Diseases Players Market Share in 2025
3.3 Genetic Screening for Carrier Diseases Market: Overall Company Footprint Analysis
3.3.1 Genetic Screening for Carrier Diseases Market: Region Footprint
3.3.2 Genetic Screening for Carrier Diseases Market: Company Product Type Footprint
3.3.3 Genetic Screening for Carrier Diseases Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Genetic Screening for Carrier Diseases Consumption Value and Market Share by Type (2021-2026)
4.2 Global Genetic Screening for Carrier Diseases Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Genetic Screening for Carrier Diseases Consumption Value Market Share by Application (2021-2026)
5.2 Global Genetic Screening for Carrier Diseases Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Genetic Screening for Carrier Diseases Consumption Value by Type (2021-2032)
6.2 North America Genetic Screening for Carrier Diseases Market Size by Application (2021-2032)
6.3 North America Genetic Screening for Carrier Diseases Market Size by Country
6.3.1 North America Genetic Screening for Carrier Diseases Consumption Value by Country (2021-2032)
6.3.2 United States Genetic Screening for Carrier Diseases Market Size and Forecast (2021-2032)
6.3.3 Canada Genetic Screening for Carrier Diseases Market Size and Forecast (2021-2032)
6.3.4 Mexico Genetic Screening for Carrier Diseases Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Genetic Screening for Carrier Diseases Consumption Value by Type (2021-2032)
7.2 Europe Genetic Screening for Carrier Diseases Consumption Value by Application (2021-2032)
7.3 Europe Genetic Screening for Carrier Diseases Market Size by Country
7.3.1 Europe Genetic Screening for Carrier Diseases Consumption Value by Country (2021-2032)
7.3.2 Germany Genetic Screening for Carrier Diseases Market Size and Forecast (2021-2032)
7.3.3 France Genetic Screening for Carrier Diseases Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Genetic Screening for Carrier Diseases Market Size and Forecast (2021-2032)
7.3.5 Russia Genetic Screening for Carrier Diseases Market Size and Forecast (2021-2032)
7.3.6 Italy Genetic Screening for Carrier Diseases Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Genetic Screening for Carrier Diseases Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Genetic Screening for Carrier Diseases Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Genetic Screening for Carrier Diseases Market Size by Region
8.3.1 Asia-Pacific Genetic Screening for Carrier Diseases Consumption Value by Region (2021-2032)
8.3.2 China Genetic Screening for Carrier Diseases Market Size and Forecast (2021-2032)
8.3.3 Japan Genetic Screening for Carrier Diseases Market Size and Forecast (2021-2032)
8.3.4 South Korea Genetic Screening for Carrier Diseases Market Size and Forecast (2021-2032)
8.3.5 India Genetic Screening for Carrier Diseases Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Genetic Screening for Carrier Diseases Market Size and Forecast (2021-2032)
8.3.7 Australia Genetic Screening for Carrier Diseases Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Genetic Screening for Carrier Diseases Consumption Value by Type (2021-2032)
9.2 South America Genetic Screening for Carrier Diseases Consumption Value by Application (2021-2032)
9.3 South America Genetic Screening for Carrier Diseases Market Size by Country
9.3.1 South America Genetic Screening for Carrier Diseases Consumption Value by Country (2021-2032)
9.3.2 Brazil Genetic Screening for Carrier Diseases Market Size and Forecast (2021-2032)
9.3.3 Argentina Genetic Screening for Carrier Diseases Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Genetic Screening for Carrier Diseases Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Genetic Screening for Carrier Diseases Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Genetic Screening for Carrier Diseases Market Size by Country
10.3.1 Middle East & Africa Genetic Screening for Carrier Diseases Consumption Value by Country (2021-2032)
10.3.2 Turkey Genetic Screening for Carrier Diseases Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Genetic Screening for Carrier Diseases Market Size and Forecast (2021-2032)
10.3.4 UAE Genetic Screening for Carrier Diseases Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Genetic Screening for Carrier Diseases Market Drivers
11.2 Genetic Screening for Carrier Diseases Market Restraints
11.3 Genetic Screening for Carrier Diseases Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Genetic Screening for Carrier Diseases Industry Chain
12.2 Genetic Screening for Carrier Diseases Upstream Analysis
12.3 Genetic Screening for Carrier Diseases Midstream Analysis
12.4 Genetic Screening for Carrier Diseases Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Genetic Screening for Carrier Diseases Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Genetic Screening for Carrier Diseases Consumption Value by Screening Timing, (USD Million), 2021 & 2025 & 2032
Table 3. Global Genetic Screening for Carrier Diseases Consumption Value by Screening Scope, (USD Million), 2021 & 2025 & 2032
Table 4. Global Genetic Screening for Carrier Diseases Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Global Genetic Screening for Carrier Diseases Consumption Value by Region (2021-2026) & (USD Million)
Table 6. Global Genetic Screening for Carrier Diseases Consumption Value by Region (2027-2032) & (USD Million)
Table 7. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 8. Thermo Fisher Scientific Major Business
Table 9. Thermo Fisher Scientific Genetic Screening for Carrier Diseases Product and Solutions
Table 10. Thermo Fisher Scientific Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 11. Thermo Fisher Scientific Recent Developments and Future Plans
Table 12. Eurofins Scientific Company Information, Head Office, and Major Competitors
Table 13. Eurofins Scientific Major Business
Table 14. Eurofins Scientific Genetic Screening for Carrier Diseases Product and Solutions
Table 15. Eurofins Scientific Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 16. Eurofins Scientific Recent Developments and Future Plans
Table 17. Illumina Company Information, Head Office, and Major Competitors
Table 18. Illumina Major Business
Table 19. Illumina Genetic Screening for Carrier Diseases Product and Solutions
Table 20. Illumina Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 21. Labcorp Company Information, Head Office, and Major Competitors
Table 22. Labcorp Major Business
Table 23. Labcorp Genetic Screening for Carrier Diseases Product and Solutions
Table 24. Labcorp Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. Labcorp Recent Developments and Future Plans
Table 26. Quest Diagnostics Company Information, Head Office, and Major Competitors
Table 27. Quest Diagnostics Major Business
Table 28. Quest Diagnostics Genetic Screening for Carrier Diseases Product and Solutions
Table 29. Quest Diagnostics Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. Quest Diagnostics Recent Developments and Future Plans
Table 31. MedGenome Company Information, Head Office, and Major Competitors
Table 32. MedGenome Major Business
Table 33. MedGenome Genetic Screening for Carrier Diseases Product and Solutions
Table 34. MedGenome Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. MedGenome Recent Developments and Future Plans
Table 36. Myriad Genetics Company Information, Head Office, and Major Competitors
Table 37. Myriad Genetics Major Business
Table 38. Myriad Genetics Genetic Screening for Carrier Diseases Product and Solutions
Table 39. Myriad Genetics Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. Myriad Genetics Recent Developments and Future Plans
Table 41. Natera Company Information, Head Office, and Major Competitors
Table 42. Natera Major Business
Table 43. Natera Genetic Screening for Carrier Diseases Product and Solutions
Table 44. Natera Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. Natera Recent Developments and Future Plans
Table 46. OPKO Health Company Information, Head Office, and Major Competitors
Table 47. OPKO Health Major Business
Table 48. OPKO Health Genetic Screening for Carrier Diseases Product and Solutions
Table 49. OPKO Health Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. OPKO Health Recent Developments and Future Plans
Table 51. 23andMe Company Information, Head Office, and Major Competitors
Table 52. 23andMe Major Business
Table 53. 23andMe Genetic Screening for Carrier Diseases Product and Solutions
Table 54. 23andMe Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. 23andMe Recent Developments and Future Plans
Table 56. Mayo Clinic Laboratories Company Information, Head Office, and Major Competitors
Table 57. Mayo Clinic Laboratories Major Business
Table 58. Mayo Clinic Laboratories Genetic Screening for Carrier Diseases Product and Solutions
Table 59. Mayo Clinic Laboratories Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. Mayo Clinic Laboratories Recent Developments and Future Plans
Table 61. Baylor Genetics Company Information, Head Office, and Major Competitors
Table 62. Baylor Genetics Major Business
Table 63. Baylor Genetics Genetic Screening for Carrier Diseases Product and Solutions
Table 64. Baylor Genetics Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Baylor Genetics Recent Developments and Future Plans
Table 66. GeneDx Company Information, Head Office, and Major Competitors
Table 67. GeneDx Major Business
Table 68. GeneDx Genetic Screening for Carrier Diseases Product and Solutions
Table 69. GeneDx Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 70. GeneDx Recent Developments and Future Plans
Table 71. Fulgent Genetics Company Information, Head Office, and Major Competitors
Table 72. Fulgent Genetics Major Business
Table 73. Fulgent Genetics Genetic Screening for Carrier Diseases Product and Solutions
Table 74. Fulgent Genetics Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 75. Fulgent Genetics Recent Developments and Future Plans
Table 76. NxGen MDx Company Information, Head Office, and Major Competitors
Table 77. NxGen MDx Major Business
Table 78. NxGen MDx Genetic Screening for Carrier Diseases Product and Solutions
Table 79. NxGen MDx Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 80. NxGen MDx Recent Developments and Future Plans
Table 81. Sonic Genetics Company Information, Head Office, and Major Competitors
Table 82. Sonic Genetics Major Business
Table 83. Sonic Genetics Genetic Screening for Carrier Diseases Product and Solutions
Table 84. Sonic Genetics Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Sonic Genetics Recent Developments and Future Plans
Table 86. Ambry Genetics Company Information, Head Office, and Major Competitors
Table 87. Ambry Genetics Major Business
Table 88. Ambry Genetics Genetic Screening for Carrier Diseases Product and Solutions
Table 89. Ambry Genetics Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. Ambry Genetics Recent Developments and Future Plans
Table 91. PreventionGenetics Company Information, Head Office, and Major Competitors
Table 92. PreventionGenetics Major Business
Table 93. PreventionGenetics Genetic Screening for Carrier Diseases Product and Solutions
Table 94. PreventionGenetics Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 95. PreventionGenetics Recent Developments and Future Plans
Table 96. DiaSorin Company Information, Head Office, and Major Competitors
Table 97. DiaSorin Major Business
Table 98. DiaSorin Genetic Screening for Carrier Diseases Product and Solutions
Table 99. DiaSorin Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 100. DiaSorin Recent Developments and Future Plans
Table 101. SYNLAB Company Information, Head Office, and Major Competitors
Table 102. SYNLAB Major Business
Table 103. SYNLAB Genetic Screening for Carrier Diseases Product and Solutions
Table 104. SYNLAB Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 105. SYNLAB Recent Developments and Future Plans
Table 106. BGI Genomics Company Information, Head Office, and Major Competitors
Table 107. BGI Genomics Major Business
Table 108. BGI Genomics Genetic Screening for Carrier Diseases Product and Solutions
Table 109. BGI Genomics Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 110. BGI Genomics Recent Developments and Future Plans
Table 111. Berry Genomics Company Information, Head Office, and Major Competitors
Table 112. Berry Genomics Major Business
Table 113. Berry Genomics Genetic Screening for Carrier Diseases Product and Solutions
Table 114. Berry Genomics Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Berry Genomics Recent Developments and Future Plans
Table 116. Annaroad Company Information, Head Office, and Major Competitors
Table 117. Annaroad Major Business
Table 118. Annaroad Genetic Screening for Carrier Diseases Product and Solutions
Table 119. Annaroad Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 120. Annaroad Recent Developments and Future Plans
Table 121. Jiajian Medical Testing Company Information, Head Office, and Major Competitors
Table 122. Jiajian Medical Testing Major Business
Table 123. Jiajian Medical Testing Genetic Screening for Carrier Diseases Product and Solutions
Table 124. Jiajian Medical Testing Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 125. Jiajian Medical Testing Recent Developments and Future Plans
Table 126. Genesky Company Information, Head Office, and Major Competitors
Table 127. Genesky Major Business
Table 128. Genesky Genetic Screening for Carrier Diseases Product and Solutions
Table 129. Genesky Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 130. Genesky Recent Developments and Future Plans
Table 131. Weihansi Biomedical Technology Company Information, Head Office, and Major Competitors
Table 132. Weihansi Biomedical Technology Major Business
Table 133. Weihansi Biomedical Technology Genetic Screening for Carrier Diseases Product and Solutions
Table 134. Weihansi Biomedical Technology Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 135. Weihansi Biomedical Technology Recent Developments and Future Plans
Table 136. Global Genetic Screening for Carrier Diseases Revenue (USD Million) by Players (2021-2026)
Table 137. Global Genetic Screening for Carrier Diseases Revenue Share by Players (2021-2026)
Table 138. Breakdown of Genetic Screening for Carrier Diseases by Company Type (Tier 1, Tier 2, and Tier 3)
Table 139. Market Position of Players in Genetic Screening for Carrier Diseases, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 140. Head Office of Key Genetic Screening for Carrier Diseases Players
Table 141. Genetic Screening for Carrier Diseases Market: Company Product Type Footprint
Table 142. Genetic Screening for Carrier Diseases Market: Company Product Application Footprint
Table 143. Genetic Screening for Carrier Diseases New Market Entrants and Barriers to Market Entry
Table 144. Genetic Screening for Carrier Diseases Mergers, Acquisition, Agreements, and Collaborations
Table 145. Global Genetic Screening for Carrier Diseases Consumption Value (USD Million) by Type (2021-2026)
Table 146. Global Genetic Screening for Carrier Diseases Consumption Value Share by Type (2021-2026)
Table 147. Global Genetic Screening for Carrier Diseases Consumption Value Forecast by Type (2027-2032)
Table 148. Global Genetic Screening for Carrier Diseases Consumption Value by Application (2021-2026)
Table 149. Global Genetic Screening for Carrier Diseases Consumption Value Forecast by Application (2027-2032)
Table 150. North America Genetic Screening for Carrier Diseases Consumption Value by Type (2021-2026) & (USD Million)
Table 151. North America Genetic Screening for Carrier Diseases Consumption Value by Type (2027-2032) & (USD Million)
Table 152. North America Genetic Screening for Carrier Diseases Consumption Value by Application (2021-2026) & (USD Million)
Table 153. North America Genetic Screening for Carrier Diseases Consumption Value by Application (2027-2032) & (USD Million)
Table 154. North America Genetic Screening for Carrier Diseases Consumption Value by Country (2021-2026) & (USD Million)
Table 155. North America Genetic Screening for Carrier Diseases Consumption Value by Country (2027-2032) & (USD Million)
Table 156. Europe Genetic Screening for Carrier Diseases Consumption Value by Type (2021-2026) & (USD Million)
Table 157. Europe Genetic Screening for Carrier Diseases Consumption Value by Type (2027-2032) & (USD Million)
Table 158. Europe Genetic Screening for Carrier Diseases Consumption Value by Application (2021-2026) & (USD Million)
Table 159. Europe Genetic Screening for Carrier Diseases Consumption Value by Application (2027-2032) & (USD Million)
Table 160. Europe Genetic Screening for Carrier Diseases Consumption Value by Country (2021-2026) & (USD Million)
Table 161. Europe Genetic Screening for Carrier Diseases Consumption Value by Country (2027-2032) & (USD Million)
Table 162. Asia-Pacific Genetic Screening for Carrier Diseases Consumption Value by Type (2021-2026) & (USD Million)
Table 163. Asia-Pacific Genetic Screening for Carrier Diseases Consumption Value by Type (2027-2032) & (USD Million)
Table 164. Asia-Pacific Genetic Screening for Carrier Diseases Consumption Value by Application (2021-2026) & (USD Million)
Table 165. Asia-Pacific Genetic Screening for Carrier Diseases Consumption Value by Application (2027-2032) & (USD Million)
Table 166. Asia-Pacific Genetic Screening for Carrier Diseases Consumption Value by Region (2021-2026) & (USD Million)
Table 167. Asia-Pacific Genetic Screening for Carrier Diseases Consumption Value by Region (2027-2032) & (USD Million)
Table 168. South America Genetic Screening for Carrier Diseases Consumption Value by Type (2021-2026) & (USD Million)
Table 169. South America Genetic Screening for Carrier Diseases Consumption Value by Type (2027-2032) & (USD Million)
Table 170. South America Genetic Screening for Carrier Diseases Consumption Value by Application (2021-2026) & (USD Million)
Table 171. South America Genetic Screening for Carrier Diseases Consumption Value by Application (2027-2032) & (USD Million)
Table 172. South America Genetic Screening for Carrier Diseases Consumption Value by Country (2021-2026) & (USD Million)
Table 173. South America Genetic Screening for Carrier Diseases Consumption Value by Country (2027-2032) & (USD Million)
Table 174. Middle East & Africa Genetic Screening for Carrier Diseases Consumption Value by Type (2021-2026) & (USD Million)
Table 175. Middle East & Africa Genetic Screening for Carrier Diseases Consumption Value by Type (2027-2032) & (USD Million)
Table 176. Middle East & Africa Genetic Screening for Carrier Diseases Consumption Value by Application (2021-2026) & (USD Million)
Table 177. Middle East & Africa Genetic Screening for Carrier Diseases Consumption Value by Application (2027-2032) & (USD Million)
Table 178. Middle East & Africa Genetic Screening for Carrier Diseases Consumption Value by Country (2021-2026) & (USD Million)
Table 179. Middle East & Africa Genetic Screening for Carrier Diseases Consumption Value by Country (2027-2032) & (USD Million)
Table 180. Global Key Players of Genetic Screening for Carrier Diseases Upstream (Raw Materials)
Table 181. Global Genetic Screening for Carrier Diseases Typical Customers
Table 1. Global Genetic Screening for Carrier Diseases Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Genetic Screening for Carrier Diseases Consumption Value by Screening Timing, (USD Million), 2021 & 2025 & 2032
Table 3. Global Genetic Screening for Carrier Diseases Consumption Value by Screening Scope, (USD Million), 2021 & 2025 & 2032
Table 4. Global Genetic Screening for Carrier Diseases Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Global Genetic Screening for Carrier Diseases Consumption Value by Region (2021-2026) & (USD Million)
Table 6. Global Genetic Screening for Carrier Diseases Consumption Value by Region (2027-2032) & (USD Million)
Table 7. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 8. Thermo Fisher Scientific Major Business
Table 9. Thermo Fisher Scientific Genetic Screening for Carrier Diseases Product and Solutions
Table 10. Thermo Fisher Scientific Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 11. Thermo Fisher Scientific Recent Developments and Future Plans
Table 12. Eurofins Scientific Company Information, Head Office, and Major Competitors
Table 13. Eurofins Scientific Major Business
Table 14. Eurofins Scientific Genetic Screening for Carrier Diseases Product and Solutions
Table 15. Eurofins Scientific Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 16. Eurofins Scientific Recent Developments and Future Plans
Table 17. Illumina Company Information, Head Office, and Major Competitors
Table 18. Illumina Major Business
Table 19. Illumina Genetic Screening for Carrier Diseases Product and Solutions
Table 20. Illumina Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 21. Labcorp Company Information, Head Office, and Major Competitors
Table 22. Labcorp Major Business
Table 23. Labcorp Genetic Screening for Carrier Diseases Product and Solutions
Table 24. Labcorp Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. Labcorp Recent Developments and Future Plans
Table 26. Quest Diagnostics Company Information, Head Office, and Major Competitors
Table 27. Quest Diagnostics Major Business
Table 28. Quest Diagnostics Genetic Screening for Carrier Diseases Product and Solutions
Table 29. Quest Diagnostics Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. Quest Diagnostics Recent Developments and Future Plans
Table 31. MedGenome Company Information, Head Office, and Major Competitors
Table 32. MedGenome Major Business
Table 33. MedGenome Genetic Screening for Carrier Diseases Product and Solutions
Table 34. MedGenome Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. MedGenome Recent Developments and Future Plans
Table 36. Myriad Genetics Company Information, Head Office, and Major Competitors
Table 37. Myriad Genetics Major Business
Table 38. Myriad Genetics Genetic Screening for Carrier Diseases Product and Solutions
Table 39. Myriad Genetics Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. Myriad Genetics Recent Developments and Future Plans
Table 41. Natera Company Information, Head Office, and Major Competitors
Table 42. Natera Major Business
Table 43. Natera Genetic Screening for Carrier Diseases Product and Solutions
Table 44. Natera Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. Natera Recent Developments and Future Plans
Table 46. OPKO Health Company Information, Head Office, and Major Competitors
Table 47. OPKO Health Major Business
Table 48. OPKO Health Genetic Screening for Carrier Diseases Product and Solutions
Table 49. OPKO Health Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. OPKO Health Recent Developments and Future Plans
Table 51. 23andMe Company Information, Head Office, and Major Competitors
Table 52. 23andMe Major Business
Table 53. 23andMe Genetic Screening for Carrier Diseases Product and Solutions
Table 54. 23andMe Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. 23andMe Recent Developments and Future Plans
Table 56. Mayo Clinic Laboratories Company Information, Head Office, and Major Competitors
Table 57. Mayo Clinic Laboratories Major Business
Table 58. Mayo Clinic Laboratories Genetic Screening for Carrier Diseases Product and Solutions
Table 59. Mayo Clinic Laboratories Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. Mayo Clinic Laboratories Recent Developments and Future Plans
Table 61. Baylor Genetics Company Information, Head Office, and Major Competitors
Table 62. Baylor Genetics Major Business
Table 63. Baylor Genetics Genetic Screening for Carrier Diseases Product and Solutions
Table 64. Baylor Genetics Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Baylor Genetics Recent Developments and Future Plans
Table 66. GeneDx Company Information, Head Office, and Major Competitors
Table 67. GeneDx Major Business
Table 68. GeneDx Genetic Screening for Carrier Diseases Product and Solutions
Table 69. GeneDx Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 70. GeneDx Recent Developments and Future Plans
Table 71. Fulgent Genetics Company Information, Head Office, and Major Competitors
Table 72. Fulgent Genetics Major Business
Table 73. Fulgent Genetics Genetic Screening for Carrier Diseases Product and Solutions
Table 74. Fulgent Genetics Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 75. Fulgent Genetics Recent Developments and Future Plans
Table 76. NxGen MDx Company Information, Head Office, and Major Competitors
Table 77. NxGen MDx Major Business
Table 78. NxGen MDx Genetic Screening for Carrier Diseases Product and Solutions
Table 79. NxGen MDx Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 80. NxGen MDx Recent Developments and Future Plans
Table 81. Sonic Genetics Company Information, Head Office, and Major Competitors
Table 82. Sonic Genetics Major Business
Table 83. Sonic Genetics Genetic Screening for Carrier Diseases Product and Solutions
Table 84. Sonic Genetics Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Sonic Genetics Recent Developments and Future Plans
Table 86. Ambry Genetics Company Information, Head Office, and Major Competitors
Table 87. Ambry Genetics Major Business
Table 88. Ambry Genetics Genetic Screening for Carrier Diseases Product and Solutions
Table 89. Ambry Genetics Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. Ambry Genetics Recent Developments and Future Plans
Table 91. PreventionGenetics Company Information, Head Office, and Major Competitors
Table 92. PreventionGenetics Major Business
Table 93. PreventionGenetics Genetic Screening for Carrier Diseases Product and Solutions
Table 94. PreventionGenetics Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 95. PreventionGenetics Recent Developments and Future Plans
Table 96. DiaSorin Company Information, Head Office, and Major Competitors
Table 97. DiaSorin Major Business
Table 98. DiaSorin Genetic Screening for Carrier Diseases Product and Solutions
Table 99. DiaSorin Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 100. DiaSorin Recent Developments and Future Plans
Table 101. SYNLAB Company Information, Head Office, and Major Competitors
Table 102. SYNLAB Major Business
Table 103. SYNLAB Genetic Screening for Carrier Diseases Product and Solutions
Table 104. SYNLAB Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 105. SYNLAB Recent Developments and Future Plans
Table 106. BGI Genomics Company Information, Head Office, and Major Competitors
Table 107. BGI Genomics Major Business
Table 108. BGI Genomics Genetic Screening for Carrier Diseases Product and Solutions
Table 109. BGI Genomics Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 110. BGI Genomics Recent Developments and Future Plans
Table 111. Berry Genomics Company Information, Head Office, and Major Competitors
Table 112. Berry Genomics Major Business
Table 113. Berry Genomics Genetic Screening for Carrier Diseases Product and Solutions
Table 114. Berry Genomics Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Berry Genomics Recent Developments and Future Plans
Table 116. Annaroad Company Information, Head Office, and Major Competitors
Table 117. Annaroad Major Business
Table 118. Annaroad Genetic Screening for Carrier Diseases Product and Solutions
Table 119. Annaroad Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 120. Annaroad Recent Developments and Future Plans
Table 121. Jiajian Medical Testing Company Information, Head Office, and Major Competitors
Table 122. Jiajian Medical Testing Major Business
Table 123. Jiajian Medical Testing Genetic Screening for Carrier Diseases Product and Solutions
Table 124. Jiajian Medical Testing Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 125. Jiajian Medical Testing Recent Developments and Future Plans
Table 126. Genesky Company Information, Head Office, and Major Competitors
Table 127. Genesky Major Business
Table 128. Genesky Genetic Screening for Carrier Diseases Product and Solutions
Table 129. Genesky Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 130. Genesky Recent Developments and Future Plans
Table 131. Weihansi Biomedical Technology Company Information, Head Office, and Major Competitors
Table 132. Weihansi Biomedical Technology Major Business
Table 133. Weihansi Biomedical Technology Genetic Screening for Carrier Diseases Product and Solutions
Table 134. Weihansi Biomedical Technology Genetic Screening for Carrier Diseases Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 135. Weihansi Biomedical Technology Recent Developments and Future Plans
Table 136. Global Genetic Screening for Carrier Diseases Revenue (USD Million) by Players (2021-2026)
Table 137. Global Genetic Screening for Carrier Diseases Revenue Share by Players (2021-2026)
Table 138. Breakdown of Genetic Screening for Carrier Diseases by Company Type (Tier 1, Tier 2, and Tier 3)
Table 139. Market Position of Players in Genetic Screening for Carrier Diseases, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 140. Head Office of Key Genetic Screening for Carrier Diseases Players
Table 141. Genetic Screening for Carrier Diseases Market: Company Product Type Footprint
Table 142. Genetic Screening for Carrier Diseases Market: Company Product Application Footprint
Table 143. Genetic Screening for Carrier Diseases New Market Entrants and Barriers to Market Entry
Table 144. Genetic Screening for Carrier Diseases Mergers, Acquisition, Agreements, and Collaborations
Table 145. Global Genetic Screening for Carrier Diseases Consumption Value (USD Million) by Type (2021-2026)
Table 146. Global Genetic Screening for Carrier Diseases Consumption Value Share by Type (2021-2026)
Table 147. Global Genetic Screening for Carrier Diseases Consumption Value Forecast by Type (2027-2032)
Table 148. Global Genetic Screening for Carrier Diseases Consumption Value by Application (2021-2026)
Table 149. Global Genetic Screening for Carrier Diseases Consumption Value Forecast by Application (2027-2032)
Table 150. North America Genetic Screening for Carrier Diseases Consumption Value by Type (2021-2026) & (USD Million)
Table 151. North America Genetic Screening for Carrier Diseases Consumption Value by Type (2027-2032) & (USD Million)
Table 152. North America Genetic Screening for Carrier Diseases Consumption Value by Application (2021-2026) & (USD Million)
Table 153. North America Genetic Screening for Carrier Diseases Consumption Value by Application (2027-2032) & (USD Million)
Table 154. North America Genetic Screening for Carrier Diseases Consumption Value by Country (2021-2026) & (USD Million)
Table 155. North America Genetic Screening for Carrier Diseases Consumption Value by Country (2027-2032) & (USD Million)
Table 156. Europe Genetic Screening for Carrier Diseases Consumption Value by Type (2021-2026) & (USD Million)
Table 157. Europe Genetic Screening for Carrier Diseases Consumption Value by Type (2027-2032) & (USD Million)
Table 158. Europe Genetic Screening for Carrier Diseases Consumption Value by Application (2021-2026) & (USD Million)
Table 159. Europe Genetic Screening for Carrier Diseases Consumption Value by Application (2027-2032) & (USD Million)
Table 160. Europe Genetic Screening for Carrier Diseases Consumption Value by Country (2021-2026) & (USD Million)
Table 161. Europe Genetic Screening for Carrier Diseases Consumption Value by Country (2027-2032) & (USD Million)
Table 162. Asia-Pacific Genetic Screening for Carrier Diseases Consumption Value by Type (2021-2026) & (USD Million)
Table 163. Asia-Pacific Genetic Screening for Carrier Diseases Consumption Value by Type (2027-2032) & (USD Million)
Table 164. Asia-Pacific Genetic Screening for Carrier Diseases Consumption Value by Application (2021-2026) & (USD Million)
Table 165. Asia-Pacific Genetic Screening for Carrier Diseases Consumption Value by Application (2027-2032) & (USD Million)
Table 166. Asia-Pacific Genetic Screening for Carrier Diseases Consumption Value by Region (2021-2026) & (USD Million)
Table 167. Asia-Pacific Genetic Screening for Carrier Diseases Consumption Value by Region (2027-2032) & (USD Million)
Table 168. South America Genetic Screening for Carrier Diseases Consumption Value by Type (2021-2026) & (USD Million)
Table 169. South America Genetic Screening for Carrier Diseases Consumption Value by Type (2027-2032) & (USD Million)
Table 170. South America Genetic Screening for Carrier Diseases Consumption Value by Application (2021-2026) & (USD Million)
Table 171. South America Genetic Screening for Carrier Diseases Consumption Value by Application (2027-2032) & (USD Million)
Table 172. South America Genetic Screening for Carrier Diseases Consumption Value by Country (2021-2026) & (USD Million)
Table 173. South America Genetic Screening for Carrier Diseases Consumption Value by Country (2027-2032) & (USD Million)
Table 174. Middle East & Africa Genetic Screening for Carrier Diseases Consumption Value by Type (2021-2026) & (USD Million)
Table 175. Middle East & Africa Genetic Screening for Carrier Diseases Consumption Value by Type (2027-2032) & (USD Million)
Table 176. Middle East & Africa Genetic Screening for Carrier Diseases Consumption Value by Application (2021-2026) & (USD Million)
Table 177. Middle East & Africa Genetic Screening for Carrier Diseases Consumption Value by Application (2027-2032) & (USD Million)
Table 178. Middle East & Africa Genetic Screening for Carrier Diseases Consumption Value by Country (2021-2026) & (USD Million)
Table 179. Middle East & Africa Genetic Screening for Carrier Diseases Consumption Value by Country (2027-2032) & (USD Million)
Table 180. Global Key Players of Genetic Screening for Carrier Diseases Upstream (Raw Materials)
Table 181. Global Genetic Screening for Carrier Diseases Typical Customers
LIST OF FIGURES
Figure 1. Genetic Screening for Carrier Diseases Picture
Figure 2. Global Genetic Screening for Carrier Diseases Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Genetic Screening for Carrier Diseases Consumption Value Market Share by Type in 2025
Figure 4. NGS
Figure 5. Whole Exome Sequencing
Figure 6. Others
Figure 7. Global Genetic Screening for Carrier Diseases Consumption Value by Screening Timing, (USD Million), 2021 & 2025 & 2032
Figure 8. Global Genetic Screening for Carrier Diseases Consumption Value Market Share by Screening Timing in 2025
Figure 9. Preconception Screening
Figure 10. Prenatal Screening
Figure 11. Global Genetic Screening for Carrier Diseases Consumption Value by Screening Scope, (USD Million), 2021 & 2025 & 2032
Figure 12. Global Genetic Screening for Carrier Diseases Consumption Value Market Share by Screening Scope in 2025
Figure 13. Single-condition Screening
Figure 14. Targeted multi-condition Screening
Figure 15. Global Genetic Screening for Carrier Diseases Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 16. Genetic Screening for Carrier Diseases Consumption Value Market Share by Application in 2025
Figure 17. Couple Picture
Figure 18. Individual Picture
Figure 19. Global Genetic Screening for Carrier Diseases Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 20. Global Genetic Screening for Carrier Diseases Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 21. Global Market Genetic Screening for Carrier Diseases Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 22. Global Genetic Screening for Carrier Diseases Consumption Value Market Share by Region (2021-2032)
Figure 23. Global Genetic Screening for Carrier Diseases Consumption Value Market Share by Region in 2025
Figure 24. North America Genetic Screening for Carrier Diseases Consumption Value (2021-2032) & (USD Million)
Figure 25. Europe Genetic Screening for Carrier Diseases Consumption Value (2021-2032) & (USD Million)
Figure 26. Asia-Pacific Genetic Screening for Carrier Diseases Consumption Value (2021-2032) & (USD Million)
Figure 27. South America Genetic Screening for Carrier Diseases Consumption Value (2021-2032) & (USD Million)
Figure 28. Middle East & Africa Genetic Screening for Carrier Diseases Consumption Value (2021-2032) & (USD Million)
Figure 29. Company Three Recent Developments and Future Plans
Figure 30. Global Genetic Screening for Carrier Diseases Revenue Share by Players in 2025
Figure 31. Genetic Screening for Carrier Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 32. Market Share of Genetic Screening for Carrier Diseases by Player Revenue in 2025
Figure 33. Top 3 Genetic Screening for Carrier Diseases Players Market Share in 2025
Figure 34. Top 6 Genetic Screening for Carrier Diseases Players Market Share in 2025
Figure 35. Global Genetic Screening for Carrier Diseases Consumption Value Share by Type (2021-2026)
Figure 36. Global Genetic Screening for Carrier Diseases Market Share Forecast by Type (2027-2032)
Figure 37. Global Genetic Screening for Carrier Diseases Consumption Value Share by Application (2021-2026)
Figure 38. Global Genetic Screening for Carrier Diseases Market Share Forecast by Application (2027-2032)
Figure 39. North America Genetic Screening for Carrier Diseases Consumption Value Market Share by Type (2021-2032)
Figure 40. North America Genetic Screening for Carrier Diseases Consumption Value Market Share by Application (2021-2032)
Figure 41. North America Genetic Screening for Carrier Diseases Consumption Value Market Share by Country (2021-2032)
Figure 42. United States Genetic Screening for Carrier Diseases Consumption Value (2021-2032) & (USD Million)
Figure 43. Canada Genetic Screening for Carrier Diseases Consumption Value (2021-2032) & (USD Million)
Figure 44. Mexico Genetic Screening for Carrier Diseases Consumption Value (2021-2032) & (USD Million)
Figure 45. Europe Genetic Screening for Carrier Diseases Consumption Value Market Share by Type (2021-2032)
Figure 46. Europe Genetic Screening for Carrier Diseases Consumption Value Market Share by Application (2021-2032)
Figure 47. Europe Genetic Screening for Carrier Diseases Consumption Value Market Share by Country (2021-2032)
Figure 48. Germany Genetic Screening for Carrier Diseases Consumption Value (2021-2032) & (USD Million)
Figure 49. France Genetic Screening for Carrier Diseases Consumption Value (2021-2032) & (USD Million)
Figure 50. United Kingdom Genetic Screening for Carrier Diseases Consumption Value (2021-2032) & (USD Million)
Figure 51. Russia Genetic Screening for Carrier Diseases Consumption Value (2021-2032) & (USD Million)
Figure 52. Italy Genetic Screening for Carrier Diseases Consumption Value (2021-2032) & (USD Million)
Figure 53. Asia-Pacific Genetic Screening for Carrier Diseases Consumption Value Market Share by Type (2021-2032)
Figure 54. Asia-Pacific Genetic Screening for Carrier Diseases Consumption Value Market Share by Application (2021-2032)
Figure 55. Asia-Pacific Genetic Screening for Carrier Diseases Consumption Value Market Share by Region (2021-2032)
Figure 56. China Genetic Screening for Carrier Diseases Consumption Value (2021-2032) & (USD Million)
Figure 57. Japan Genetic Screening for Carrier Diseases Consumption Value (2021-2032) & (USD Million)
Figure 58. South Korea Genetic Screening for Carrier Diseases Consumption Value (2021-2032) & (USD Million)
Figure 59. India Genetic Screening for Carrier Diseases Consumption Value (2021-2032) & (USD Million)
Figure 60. Southeast Asia Genetic Screening for Carrier Diseases Consumption Value (2021-2032) & (USD Million)
Figure 61. Australia Genetic Screening for Carrier Diseases Consumption Value (2021-2032) & (USD Million)
Figure 62. South America Genetic Screening for Carrier Diseases Consumption Value Market Share by Type (2021-2032)
Figure 63. South America Genetic Screening for Carrier Diseases Consumption Value Market Share by Application (2021-2032)
Figure 64. South America Genetic Screening for Carrier Diseases Consumption Value Market Share by Country (2021-2032)
Figure 65. Brazil Genetic Screening for Carrier Diseases Consumption Value (2021-2032) & (USD Million)
Figure 66. Argentina Genetic Screening for Carrier Diseases Consumption Value (2021-2032) & (USD Million)
Figure 67. Middle East & Africa Genetic Screening for Carrier Diseases Consumption Value Market Share by Type (2021-2032)
Figure 68. Middle East & Africa Genetic Screening for Carrier Diseases Consumption Value Market Share by Application (2021-2032)
Figure 69. Middle East & Africa Genetic Screening for Carrier Diseases Consumption Value Market Share by Country (2021-2032)
Figure 70. Turkey Genetic Screening for Carrier Diseases Consumption Value (2021-2032) & (USD Million)
Figure 71. Saudi Arabia Genetic Screening for Carrier Diseases Consumption Value (2021-2032) & (USD Million)
Figure 72. UAE Genetic Screening for Carrier Diseases Consumption Value (2021-2032) & (USD Million)
Figure 73. Genetic Screening for Carrier Diseases Market Drivers
Figure 74. Genetic Screening for Carrier Diseases Market Restraints
Figure 75. Genetic Screening for Carrier Diseases Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Genetic Screening for Carrier Diseases Industrial Chain
Figure 78. Methodology
Figure 79. Research Process and Data Source
Figure 1. Genetic Screening for Carrier Diseases Picture
Figure 2. Global Genetic Screening for Carrier Diseases Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Genetic Screening for Carrier Diseases Consumption Value Market Share by Type in 2025
Figure 4. NGS
Figure 5. Whole Exome Sequencing
Figure 6. Others
Figure 7. Global Genetic Screening for Carrier Diseases Consumption Value by Screening Timing, (USD Million), 2021 & 2025 & 2032
Figure 8. Global Genetic Screening for Carrier Diseases Consumption Value Market Share by Screening Timing in 2025
Figure 9. Preconception Screening
Figure 10. Prenatal Screening
Figure 11. Global Genetic Screening for Carrier Diseases Consumption Value by Screening Scope, (USD Million), 2021 & 2025 & 2032
Figure 12. Global Genetic Screening for Carrier Diseases Consumption Value Market Share by Screening Scope in 2025
Figure 13. Single-condition Screening
Figure 14. Targeted multi-condition Screening
Figure 15. Global Genetic Screening for Carrier Diseases Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 16. Genetic Screening for Carrier Diseases Consumption Value Market Share by Application in 2025
Figure 17. Couple Picture
Figure 18. Individual Picture
Figure 19. Global Genetic Screening for Carrier Diseases Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 20. Global Genetic Screening for Carrier Diseases Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 21. Global Market Genetic Screening for Carrier Diseases Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 22. Global Genetic Screening for Carrier Diseases Consumption Value Market Share by Region (2021-2032)
Figure 23. Global Genetic Screening for Carrier Diseases Consumption Value Market Share by Region in 2025
Figure 24. North America Genetic Screening for Carrier Diseases Consumption Value (2021-2032) & (USD Million)
Figure 25. Europe Genetic Screening for Carrier Diseases Consumption Value (2021-2032) & (USD Million)
Figure 26. Asia-Pacific Genetic Screening for Carrier Diseases Consumption Value (2021-2032) & (USD Million)
Figure 27. South America Genetic Screening for Carrier Diseases Consumption Value (2021-2032) & (USD Million)
Figure 28. Middle East & Africa Genetic Screening for Carrier Diseases Consumption Value (2021-2032) & (USD Million)
Figure 29. Company Three Recent Developments and Future Plans
Figure 30. Global Genetic Screening for Carrier Diseases Revenue Share by Players in 2025
Figure 31. Genetic Screening for Carrier Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 32. Market Share of Genetic Screening for Carrier Diseases by Player Revenue in 2025
Figure 33. Top 3 Genetic Screening for Carrier Diseases Players Market Share in 2025
Figure 34. Top 6 Genetic Screening for Carrier Diseases Players Market Share in 2025
Figure 35. Global Genetic Screening for Carrier Diseases Consumption Value Share by Type (2021-2026)
Figure 36. Global Genetic Screening for Carrier Diseases Market Share Forecast by Type (2027-2032)
Figure 37. Global Genetic Screening for Carrier Diseases Consumption Value Share by Application (2021-2026)
Figure 38. Global Genetic Screening for Carrier Diseases Market Share Forecast by Application (2027-2032)
Figure 39. North America Genetic Screening for Carrier Diseases Consumption Value Market Share by Type (2021-2032)
Figure 40. North America Genetic Screening for Carrier Diseases Consumption Value Market Share by Application (2021-2032)
Figure 41. North America Genetic Screening for Carrier Diseases Consumption Value Market Share by Country (2021-2032)
Figure 42. United States Genetic Screening for Carrier Diseases Consumption Value (2021-2032) & (USD Million)
Figure 43. Canada Genetic Screening for Carrier Diseases Consumption Value (2021-2032) & (USD Million)
Figure 44. Mexico Genetic Screening for Carrier Diseases Consumption Value (2021-2032) & (USD Million)
Figure 45. Europe Genetic Screening for Carrier Diseases Consumption Value Market Share by Type (2021-2032)
Figure 46. Europe Genetic Screening for Carrier Diseases Consumption Value Market Share by Application (2021-2032)
Figure 47. Europe Genetic Screening for Carrier Diseases Consumption Value Market Share by Country (2021-2032)
Figure 48. Germany Genetic Screening for Carrier Diseases Consumption Value (2021-2032) & (USD Million)
Figure 49. France Genetic Screening for Carrier Diseases Consumption Value (2021-2032) & (USD Million)
Figure 50. United Kingdom Genetic Screening for Carrier Diseases Consumption Value (2021-2032) & (USD Million)
Figure 51. Russia Genetic Screening for Carrier Diseases Consumption Value (2021-2032) & (USD Million)
Figure 52. Italy Genetic Screening for Carrier Diseases Consumption Value (2021-2032) & (USD Million)
Figure 53. Asia-Pacific Genetic Screening for Carrier Diseases Consumption Value Market Share by Type (2021-2032)
Figure 54. Asia-Pacific Genetic Screening for Carrier Diseases Consumption Value Market Share by Application (2021-2032)
Figure 55. Asia-Pacific Genetic Screening for Carrier Diseases Consumption Value Market Share by Region (2021-2032)
Figure 56. China Genetic Screening for Carrier Diseases Consumption Value (2021-2032) & (USD Million)
Figure 57. Japan Genetic Screening for Carrier Diseases Consumption Value (2021-2032) & (USD Million)
Figure 58. South Korea Genetic Screening for Carrier Diseases Consumption Value (2021-2032) & (USD Million)
Figure 59. India Genetic Screening for Carrier Diseases Consumption Value (2021-2032) & (USD Million)
Figure 60. Southeast Asia Genetic Screening for Carrier Diseases Consumption Value (2021-2032) & (USD Million)
Figure 61. Australia Genetic Screening for Carrier Diseases Consumption Value (2021-2032) & (USD Million)
Figure 62. South America Genetic Screening for Carrier Diseases Consumption Value Market Share by Type (2021-2032)
Figure 63. South America Genetic Screening for Carrier Diseases Consumption Value Market Share by Application (2021-2032)
Figure 64. South America Genetic Screening for Carrier Diseases Consumption Value Market Share by Country (2021-2032)
Figure 65. Brazil Genetic Screening for Carrier Diseases Consumption Value (2021-2032) & (USD Million)
Figure 66. Argentina Genetic Screening for Carrier Diseases Consumption Value (2021-2032) & (USD Million)
Figure 67. Middle East & Africa Genetic Screening for Carrier Diseases Consumption Value Market Share by Type (2021-2032)
Figure 68. Middle East & Africa Genetic Screening for Carrier Diseases Consumption Value Market Share by Application (2021-2032)
Figure 69. Middle East & Africa Genetic Screening for Carrier Diseases Consumption Value Market Share by Country (2021-2032)
Figure 70. Turkey Genetic Screening for Carrier Diseases Consumption Value (2021-2032) & (USD Million)
Figure 71. Saudi Arabia Genetic Screening for Carrier Diseases Consumption Value (2021-2032) & (USD Million)
Figure 72. UAE Genetic Screening for Carrier Diseases Consumption Value (2021-2032) & (USD Million)
Figure 73. Genetic Screening for Carrier Diseases Market Drivers
Figure 74. Genetic Screening for Carrier Diseases Market Restraints
Figure 75. Genetic Screening for Carrier Diseases Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Genetic Screening for Carrier Diseases Industrial Chain
Figure 78. Methodology
Figure 79. Research Process and Data Source
